| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein-glutamine gamma-glutamyltransferase activity | 6.30e-05 | 9 | 27 | 2 | GO:0003810 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 4.93e-04 | 775 | 27 | 6 | GO:0016746 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 6.54e-04 | 532 | 27 | 5 | GO:0016755 | |
| Domain | Transglut_N | 7.20e-05 | 9 | 27 | 2 | PF00868 | |
| Domain | TRANSGLUTAMINASES | 7.20e-05 | 9 | 27 | 2 | PS00547 | |
| Domain | Transglutaminase_N | 7.20e-05 | 9 | 27 | 2 | IPR001102 | |
| Domain | Transglut_C | 7.20e-05 | 9 | 27 | 2 | PF00927 | |
| Domain | - | 7.20e-05 | 9 | 27 | 2 | 3.90.260.10 | |
| Domain | Gln_gamma-glutamylTfrase_euk | 7.20e-05 | 9 | 27 | 2 | IPR023608 | |
| Domain | Transglutaminase_AS | 7.20e-05 | 9 | 27 | 2 | IPR013808 | |
| Domain | Transglutaminase_C | 8.99e-05 | 10 | 27 | 2 | IPR008958 | |
| Domain | TGc | 1.10e-04 | 11 | 27 | 2 | SM00460 | |
| Domain | Transglut_core | 1.10e-04 | 11 | 27 | 2 | PF01841 | |
| Domain | Transglutaminase-like | 1.10e-04 | 11 | 27 | 2 | IPR002931 | |
| Domain | WD40_repeat | 5.93e-04 | 272 | 27 | 4 | IPR001680 | |
| Domain | WD_REPEATS_1 | 6.44e-04 | 278 | 27 | 4 | PS00678 | |
| Domain | WD_REPEATS_2 | 6.52e-04 | 279 | 27 | 4 | PS50082 | |
| Domain | WD_REPEATS_REGION | 6.52e-04 | 279 | 27 | 4 | PS50294 | |
| Domain | GPS | 1.10e-03 | 34 | 27 | 2 | SM00303 | |
| Domain | GPS | 1.16e-03 | 35 | 27 | 2 | PF01825 | |
| Domain | GPS | 1.23e-03 | 36 | 27 | 2 | PS50221 | |
| Domain | GPS | 1.30e-03 | 37 | 27 | 2 | IPR000203 | |
| Domain | WD40_repeat_CS | 1.67e-03 | 164 | 27 | 3 | IPR019775 | |
| Domain | WD40 | 6.03e-03 | 259 | 27 | 3 | PF00400 | |
| Domain | WD40 | 6.62e-03 | 268 | 27 | 3 | SM00320 | |
| Domain | WD40_repeat_dom | 8.78e-03 | 297 | 27 | 3 | IPR017986 | |
| Domain | Ig_E-set | 9.84e-03 | 104 | 27 | 2 | IPR014756 | |
| Domain | - | 1.20e-02 | 333 | 27 | 3 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 1.22e-02 | 335 | 27 | 3 | IPR015943 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 20406802 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 21625513 | ||
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 11390390 | ||
| Pubmed | 1.74e-05 | 8 | 28 | 2 | 7906657 | ||
| Pubmed | 1.74e-05 | 8 | 28 | 2 | 7688299 | ||
| Pubmed | 4.78e-04 | 40 | 28 | 2 | 27197753 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 6.54e-04 | 212 | 28 | 3 | 33853758 | |
| Pubmed | PIKES Analysis Reveals Response to Degraders and Key Regulatory Mechanisms of the CRL4 Network. | 7.18e-04 | 49 | 28 | 2 | 31973889 | |
| Pubmed | SUMOylation of DDX39A Alters Binding and Export of Antiviral Transcripts to Control Innate Immunity. | 7.41e-04 | 915 | 28 | 5 | 32393512 | |
| Cytoband | 9p22.3 | 2.79e-05 | 13 | 28 | 2 | 9p22.3 | |
| Cytoband | 15q15.2 | 4.28e-05 | 16 | 28 | 2 | 15q15.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p22 | 4.85e-04 | 53 | 28 | 2 | chr9p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 3.64e-03 | 147 | 28 | 2 | chr15q15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q31 | 5.29e-03 | 178 | 28 | 2 | chr2q31 | |
| GeneFamily | Transglutaminases | 5.06e-05 | 9 | 22 | 2 | 773 | |
| GeneFamily | WD repeat domain containing | 3.78e-03 | 262 | 22 | 3 | 362 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.18e-06 | 163 | 28 | 4 | e6213900f56257fe38ac7852351bea0340294be0 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.18e-06 | 163 | 28 | 4 | ed7319185c1ec384444309bb8be95691a0c2091c | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.18e-06 | 163 | 28 | 4 | ef35d7ff09aa364734fea7fdaab6260c0a3fbf09 | |
| ToppCell | T_cells-GZMK+_CD8+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 4.60e-06 | 179 | 28 | 4 | 798f208014f2229c597934775646ddbbacf94b69 | |
| ToppCell | T_cells-GZMK+_CD8+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 5.71e-06 | 189 | 28 | 4 | e2ca075aedf7c370ab4ede6272254ffd06cbcdec | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.20e-06 | 193 | 28 | 4 | a594f89a18273797506287d9e22f72abe53e4920 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.59e-06 | 196 | 28 | 4 | 511e9846d204b2346b17d1a4142c3bb484b08e32 | |
| ToppCell | ILEUM-non-inflamed-(6)_ILC-(6)_ILC1|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.59e-06 | 196 | 28 | 4 | 8a3a63129adfbe58558af91336f81d397c291ed0 | |
| ToppCell | ILEUM-inflamed-(6)_ILC-(6)_ILC1|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.59e-06 | 196 | 28 | 4 | c1d84d2e4ecc83134c3c694bed3cf035bd2742af | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT1-AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.70e-05 | 112 | 28 | 3 | 456278fb92dd41820fde8cf27c68fec45e15f972 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-iNKT/MAIT-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.09e-05 | 115 | 28 | 3 | 3ab39d28717ae585d84c0e0686508faab2fc2e3b | |
| ToppCell | Posterior_cortex|World / BrainAtlas - Mouse McCarroll V32 | 1.33e-04 | 159 | 28 | 3 | 18e9fe2efbe0bca7c3990f3b12b6f549e2c1263a | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.35e-04 | 160 | 28 | 3 | 8e2b51d7b42e0b6e62641efdbbc73d31561d6a3e | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT-T-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.35e-04 | 160 | 28 | 3 | 5c931e859acf67c1c8664941e0e44d195f8ba75b | |
| ToppCell | facs-GAT-Fat-24m-Lymphocytic-NK_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 163 | 28 | 3 | e58863a462cc504bced627f004a47890ee2307ce | |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic-B_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 166 | 28 | 3 | 4b31d2755108b2815316411a38bfb11fd30ef98a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.56e-04 | 168 | 28 | 3 | 2572a3dd4f3f619bd26a3cd6e60de43821d8bb64 | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.62e-04 | 170 | 28 | 3 | 9a18756e6721980d4b6c37bb52ddfe93ca79c5ab | |
| ToppCell | URO-Lymphocyte-T_NK-gdT|URO / Disease, Lineage and Cell Type | 1.68e-04 | 172 | 28 | 3 | 97b1eb95234639fcaa5ea3c4ba7ec2f4eb929dbf | |
| ToppCell | CD8+_Memory_T_cell-FLU-3|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.68e-04 | 172 | 28 | 3 | 45ac433dbb3796f69e886c04457b2971403050ee | |
| ToppCell | FLU-Healthy-3|FLU / Virus stimulation, Condition and Cluster | 1.71e-04 | 173 | 28 | 3 | 32b8e5b400885dbeba57a7cb2c18d882664dc285 | |
| ToppCell | FLU-Healthy-3|Healthy / Virus stimulation, Condition and Cluster | 1.71e-04 | 173 | 28 | 3 | 26e89ac86922f1cd0100cf4d1cce37e74dd31c88 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-iNKT/MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.73e-04 | 174 | 28 | 3 | 61aa89b56ebda0eba1ba675d5f036992967f670f | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-04 | 175 | 28 | 3 | 98cb577df466700e72d1bbc6689205ccf2e7fcba | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-04 | 178 | 28 | 3 | 7905621f5b2aa55324c5592d1d2fef763a5fa41f | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 178 | 28 | 3 | ba5a477257877f4a15a91c1762ffcc6f2e9f7357 | |
| ToppCell | E17.5-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.85e-04 | 178 | 28 | 3 | 982205ba117a4c7b7e9b713689a5b69190f0bca9 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 178 | 28 | 3 | 5634c1fbc817758092af4feafff94d107412d89b | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-04 | 178 | 28 | 3 | f914092c20130207193f97c6044ae61a9a440a86 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-TRDV2/TRGV9_gdT|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.89e-04 | 179 | 28 | 3 | f7d3d37505893ae55065c89d957084602729decc | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 181 | 28 | 3 | 2c2b812cdd350271935d7007665c26093756ebee | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 181 | 28 | 3 | ce30724788d9b5c6dfa4f9f8d318c3d2565165ed | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Trm/em_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.98e-04 | 182 | 28 | 3 | f857b32de19240a8aca1685f7a78b4e53b04875c | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.01e-04 | 183 | 28 | 3 | a90ffd9c50caa65f537a2e441e37655e1b622327 | |
| ToppCell | Control-Lymphocytic_NKT-iNKT/MAIT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.01e-04 | 183 | 28 | 3 | 59e8d07556390828f7557ba3fd2f7d49851498b7 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.01e-04 | 183 | 28 | 3 | 13ad20ec140ef5b96fdace3369b5befc0f40bb76 | |
| ToppCell | Control-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.01e-04 | 183 | 28 | 3 | 2c5707ada3442eb7100a2a5f9438d5a2ac53a9e1 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK-CD56_bright_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.08e-04 | 185 | 28 | 3 | 593eceb3dfcc662c892a840ba29ab687c6886c01 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-NKT2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.08e-04 | 185 | 28 | 3 | 2d95713deaa05fb3372f4337ef156027e4d8ec8a | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.11e-04 | 186 | 28 | 3 | 30dd4164c101006c8d95922d89652b82dbe4b5ea | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-lymphatic_endothelial|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.11e-04 | 186 | 28 | 3 | eeacf59a9e6bf1c9fd59b6b13d35e8abae228cf0 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_NK-T_NK-CD56_bright_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.11e-04 | 186 | 28 | 3 | e0eeef2b9e06324354c5a11a4c6d4c98546f32af | |
| ToppCell | Control-Lymphoid-CD8_T_cells|Lymphoid / Condition, Lineage and Cell class | 2.11e-04 | 186 | 28 | 3 | a8a4c0f4058f5bbc435dd2dd41d55383173a1358 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-CD56_bright_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.18e-04 | 188 | 28 | 3 | 0a2be6eac6fde669fbc58fd1b2e93e4acf17ddde | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.21e-04 | 189 | 28 | 3 | f1129eb122bbc051457c5545f1a267beb988b0f2 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.21e-04 | 189 | 28 | 3 | 0b012ee301419fa9ccc387c3ff66c2344b349a97 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.25e-04 | 190 | 28 | 3 | 423b54c6d48d6981a9522043252239303dccaf04 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.25e-04 | 190 | 28 | 3 | 81e7d4f97b958b4ed14298a77104ef31a6ec6c91 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.25e-04 | 190 | 28 | 3 | a1b19028c36d192352bc8a7f187790f4b56cfe17 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.28e-04 | 191 | 28 | 3 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK-mature_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.32e-04 | 192 | 28 | 3 | e48bbcb97c113f323ad4db96bd10d593b9206923 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.32e-04 | 192 | 28 | 3 | fdc741e1846cfd8ed741b160e3c611c310c5d36d | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD8-Trm/em_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.32e-04 | 192 | 28 | 3 | 7a122505d7adf236e0cbd9bcbc98e7c537600ca3 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.32e-04 | 192 | 28 | 3 | ed1fb700d3e8f00495727d61e164fc0b70274fd0 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.32e-04 | 192 | 28 | 3 | ab88ea7723f0fa3b39611981c043445f27425404 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.32e-04 | 192 | 28 | 3 | 6779b0294bb058e748e22b795b6a381c4add37e9 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-NK_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-04 | 192 | 28 | 3 | ec084cc4edb2ccd4e8fa646026ce89c39d7a0893 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.35e-04 | 193 | 28 | 3 | 6e1498153a7766c03fddbda1701dbf1596d21736 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 2.35e-04 | 193 | 28 | 3 | c2673d86f7d7b849788036032a93a6d136a70040 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-CD8_Tmem|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.35e-04 | 193 | 28 | 3 | 53b3f9a8967541ca817a250439a7928d36b45386 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 2.35e-04 | 193 | 28 | 3 | 48809047d3194aff225fc43c3d5152c20434fe62 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-CD8_Tmem|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.35e-04 | 193 | 28 | 3 | 30db4ddfdeb225cc934cf52af1fbcccfdaeb6223 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-CD8_low_T|normal_Lymph_Node / Location, Cell class and cell subclass | 2.35e-04 | 193 | 28 | 3 | e20ad6b62ad3aa386aa10b7a5d057d24a64ad386 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-NKT1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.35e-04 | 193 | 28 | 3 | 52f42ec293a5077a44de5c27e89b57c23944e560 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.35e-04 | 193 | 28 | 3 | fce4f805e53669acb4c188f87ac7d84408c0c218 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.39e-04 | 194 | 28 | 3 | 5a859885c0f9b8554b0d203e371c70928ad4418f | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.39e-04 | 194 | 28 | 3 | bf2480acec5612cd8a3c33d3e7a98176dc6c9091 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_memory_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.39e-04 | 194 | 28 | 3 | 866a9ca4c93c3c79c709a9d00def5392197f7e18 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.39e-04 | 194 | 28 | 3 | 7d35ac70ba966eb1fee4197f7de6d6116326a442 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-innate_lymphocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.39e-04 | 194 | 28 | 3 | 8bfd7c5be518b81b17913139bcb3ebea01f48dd5 | |
| ToppCell | (0)_Myeloid-(00)_Monocyte-(001)_CD16+_Monocyte|(00)_Monocyte / immune cells in Peripheral Blood (logTPM normalization) | 2.39e-04 | 194 | 28 | 3 | 89cb262e04d7105012e957e0add44c73de6c1ed0 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Naive_CD8+_T|normal_Lymph_Node / Location, Cell class and cell subclass | 2.39e-04 | 194 | 28 | 3 | 81b8f60d3b81e494051721ce9b8b6aefd415442c | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.39e-04 | 194 | 28 | 3 | 5afe7f48d3383f3dac18765f97999c8b6936dc1b | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.39e-04 | 194 | 28 | 3 | f0707601883b234ed477c7704ca9a88efaefc3fd | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.39e-04 | 194 | 28 | 3 | 95ab357d5f7bf91ba287417928c8575e655814fc | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-NK_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.39e-04 | 194 | 28 | 3 | 3fe32e38c95135d152acb1624fec1623339e144a | |
| ToppCell | (0)_Myeloid-(001)_CD16+_Monocyte|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization) | 2.39e-04 | 194 | 28 | 3 | 4240d0b3cf264f51dcf0cb4d0a18641d85d38638 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.39e-04 | 194 | 28 | 3 | ec7e0ca6c9a2f63938e06ee771da09eff14fc3b5 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.39e-04 | 194 | 28 | 3 | 5031f324628ff12a33e84cc52157be4786e0961d | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.42e-04 | 195 | 28 | 3 | 609732e83ab7fc3ba7dace66f5a17e46557fd6d1 | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK-NK_CD16|Lung / Manually curated celltypes from each tissue | 2.42e-04 | 195 | 28 | 3 | e91e7f89163c615b706f3297b641b1e4c966f5e6 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.42e-04 | 195 | 28 | 3 | 1a7c2c4cf30df435770794a989be438579bf98f2 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.46e-04 | 196 | 28 | 3 | 8e1ed30256a031bb90dac1f167e074c68efbed74 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.46e-04 | 196 | 28 | 3 | 0f3c7fd450aaa1f866b8558692534c0ea2a34e75 | |
| ToppCell | critical-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.46e-04 | 196 | 28 | 3 | c861f017aa9050282aa81c5a445bae399df00e4f | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.46e-04 | 196 | 28 | 3 | 4e1f8828413896ab8a4ec92a89d6789e8e37e05a | |
| ToppCell | T_cells-GZMK+_T_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.46e-04 | 196 | 28 | 3 | fa5c7fec9e0dcd7e62ff64704bfdf2a3437a43ba | |
| ToppCell | Control-Lymphocyte-T_NK-NK_CD56bright|Control / Disease, Lineage and Cell Type | 2.46e-04 | 196 | 28 | 3 | c0ebef067aa333c7a18c697031b0417b3335b75c | |
| ToppCell | T_cells-GZMK+GZMB+_T_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.46e-04 | 196 | 28 | 3 | b237287def04def371191b054a41ec0b3150da75 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.46e-04 | 196 | 28 | 3 | 5b5cf6f70534661d694f47359b6595b4580876c3 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.50e-04 | 197 | 28 | 3 | 927bf36bad3bcb7346c13b660777c1c0de7dc322 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.50e-04 | 197 | 28 | 3 | 3e09158507df08c08e08613ce23617206280c911 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-Activated_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.50e-04 | 197 | 28 | 3 | dfec2afd1cbe218c9234ce7d4b5a5839b268398d | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.50e-04 | 197 | 28 | 3 | 879974aff3f887648a00b4659b46d9897c9eb467 | |
| ToppCell | Mild-CD8+_T_activated|Mild / Disease group and Cell class | 2.54e-04 | 198 | 28 | 3 | ceac1b51bacfd0dd7fe7c6a666f7927055e1f380 | |
| ToppCell | COVID-19_Moderate-CD8+_Tem|World / disease group, cell group and cell class | 2.54e-04 | 198 | 28 | 3 | 1d12be256af028c88e31fb535068bae16b7bd48e | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_CTL|World / disease group, cell group and cell class (v2) | 2.54e-04 | 198 | 28 | 3 | 03c01fc384d46eec55ff730edbab8a3fde618ed8 | |
| ToppCell | LPS_only-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-iNKT-MAIT|LPS_only / Treatment groups by lineage, cell group, cell type | 2.57e-04 | 199 | 28 | 3 | b62a756b5472972156d05051a58671a58bef1f16 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-iNKT-MAIT|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.57e-04 | 199 | 28 | 3 | c23a53a20487a8abfeb91fa5fc9c06823dd657e9 | |
| ToppCell | COVID-19-Lymphoid-CD8_T_cells|COVID-19 / Condition, Lineage and Cell class | 2.57e-04 | 199 | 28 | 3 | 8e322d0d097df160554e3024ec9edae4a77a66cc | |
| Disease | skin aging measurement | 6.64e-04 | 181 | 28 | 3 | EFO_0008006 | |
| Disease | microglial activation measurement | 1.44e-03 | 59 | 28 | 2 | EFO_0010940 | |
| Disease | Manic Disorder | 2.07e-03 | 71 | 28 | 2 | C0024713 | |
| Disease | Manic | 2.49e-03 | 78 | 28 | 2 | C0338831 | |
| Disease | Depression, Bipolar | 2.56e-03 | 79 | 28 | 2 | C0005587 | |
| Disease | physical activity | 3.16e-03 | 88 | 28 | 2 | EFO_0003940 | |
| Disease | sunburn | 3.75e-03 | 96 | 28 | 2 | EFO_0003958 | |
| Disease | cognitive function measurement, self reported educational attainment | 4.53e-03 | 355 | 28 | 3 | EFO_0004784, EFO_0008354 | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 6.21e-03 | 398 | 28 | 3 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | Vertigo | 7.69e-03 | 139 | 28 | 2 | HP_0002321 | |
| Disease | Crohn's disease | 8.23e-03 | 441 | 28 | 3 | EFO_0000384 | |
| Disease | adiponectin measurement | 8.45e-03 | 146 | 28 | 2 | EFO_0004502 | |
| Disease | nasopharyngeal neoplasm | 9.01e-03 | 151 | 28 | 2 | EFO_0004252 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VAWHWVFGSFLCKMV | 106 | O00590 | |
| PEMRFFHWFSKWRKL | 66 | Q9HC16 | |
| CDCNILWMHRWVKEK | 191 | Q8IWK6 | |
| LLVMKHRWKSFFHWS | 241 | Q9H6U8 | |
| TICFWQWHVKTMKFR | 291 | Q6RI45 | |
| CHALDQWRKGWFAMD | 1026 | Q8WZ64 | |
| FRKKCFKEWMAHWNA | 86 | Q9NZJ0 | |
| VCWLVMENFKEHHWK | 1456 | Q9P1Z9 | |
| MARVRCADASHFWKW | 401 | Q99650 | |
| AETHKWAWFRRYCMA | 3866 | O95714 | |
| GRHVDIFKFWLMWKA | 456 | Q99259 | |
| FRWKEDICAFIEKHW | 146 | Q9H8E8 | |
| FLACHLAMWKKLAEW | 146 | O15297 | |
| RWFDRKHEQCMKHIW | 261 | Q5T197 | |
| ADCMKWIVKHFARFW | 336 | Q5XKL5 | |
| FDEFKWMCVAAWHRE | 171 | Q8N6U8 | |
| KCKDFKWFMAAVAWD | 426 | Q49A17 | |
| VVMYFWKRFCFWKAT | 971 | A5PLK6 | |
| VFDHRMKCWQKWEDA | 406 | O60749 | |
| WKMLSEIWHRFLSKC | 281 | Q8NHV1 | |
| DMAVKRKWHFLCNCW | 831 | Q7Z443 | |
| KHWLWTRKCFVCKMY | 346 | Q92966 | |
| DEFWDKKVTHFCFWK | 101 | Q86VW0 | |
| KHWRKMLWRFISLFS | 106 | Q86WR6 | |
| WKQFHHLCYWELMWI | 426 | Q5VTQ0 | |
| HFSTVWLCWDMQGKR | 91 | P78362 | |
| FHVWNECWMARKDLP | 336 | O43548 | |
| TMVKWWDLDTQHCFK | 171 | Q9UNX4 | |
| NFHVWNECWMIRKDL | 336 | Q96PF1 |